Phase I/II randomised, double-blind, placebo-controlled trial of trabodenoson [INO 8875] in patients with primary open-angle glaucoma or ocular hypertension

Trial Profile

Phase I/II randomised, double-blind, placebo-controlled trial of trabodenoson [INO 8875] in patients with primary open-angle glaucoma or ocular hypertension

Completed
Phase of Trial: Phase I/II

Latest Information Update: 08 Oct 2013

At a glance

  • Drugs Trabodenoson (Primary)
  • Indications Ocular hypertension; Open-angle glaucoma
  • Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
  • Sponsors Inotek Pharmaceuticals
  • Most Recent Events

    • 08 Oct 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top